Parexel’s TGN 1412 U.K. Drug Trial: The Official Report

The New Scientist just published an article summarizing findings from the official MHRA report on "what went wrong" in the March clinical trials. No manufacturing or dosing errors were found, but the case offers other lessons in best clinical trials practices. -AMS